Comparative analysis of adverse events between infliximab and adalimumab in Crohn's disease management: a Brazilian single-centre experience
- Alternative title
-
Análise comparativa dos eventos adversos entre Infliximabe e Adalimumabe no tratamento da doença de Crohn: experiência em um centro brasileiro
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Comparative analysis of adverse events between infliximab and adalimumab in Crohn's disease management: a Brazilian single-centre experience ; volume:33 ; number:01 ; year:2013 ; pages:033-038
Journal of coloproctology ; 33, Heft 01 (2013), 033-038
- Contributor
-
Kotze, Paulo Gustavo
Akiyoshi, Fernando Kenji
Luvizotto, Mateus
Olandoski, Márcia
Kotze, Lorete Maria da Silva
Coy, Cláudio Saddy Rodrigues
- DOI
-
10.1016/j.jcol.2013.03.001
- URN
-
urn:nbn:de:101:1-2021031209170501316335
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:26 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kotze, Paulo Gustavo
- Akiyoshi, Fernando Kenji
- Luvizotto, Mateus
- Olandoski, Márcia
- Kotze, Lorete Maria da Silva
- Coy, Cláudio Saddy Rodrigues
Other Objects (12)
Comparison between infliximab and adalimumab in the treatment of perianal fistulas in Crohn's disease
Adalimumab Dose-Escalation Therapy Is Effective in Refractory Crohn’s Disease Patients with Loss of Response to Adalimumab, Especially in Cases without Previous Infliximab Treatment
A Retrospective Claims Database Study on Drug Utilization in Japanese Patients with Crohn’s Disease Treated with Adalimumab or Infliximab
Subcutaneous infliximab in Crohn’s disease patients with previous immunogenic failure of intravenous infliximab
Duodenal Crohn’s disease successfully treated with adalimumab
Adalimumab for orbital myositis in a patient with Crohn’s disease who discontinued infliximab: a case report and review of the literature
Comparative real-world outcomes between ustekinumab, infliximab, and adalimumab in bio-naïve and bio-experienced Crohn’s disease patients: a retrospective multicenter study
Leukocytoclastic Vasculitis Associated with Adalimumab Therapy for Crohn’s Disease
Hodgkin's Lymphoma in Crohn's Disease Treated with Infliximab
Infliximab und Adalimumab in der Therapie der Colitis ulcerosa : eine retrospektive Analyse
Efficacy and safety of infliximab and adalimumab in inflammatory bowel disease patients
Listeria Monocytogenes Brain Abscess in Crohn’s Disease Treated with Adalimumab
Comparison between infliximab and adalimumab in the treatment of perianal fistulas in Crohn's disease
Adalimumab Dose-Escalation Therapy Is Effective in Refractory Crohn’s Disease Patients with Loss of Response to Adalimumab, Especially in Cases without Previous Infliximab Treatment
A Retrospective Claims Database Study on Drug Utilization in Japanese Patients with Crohn’s Disease Treated with Adalimumab or Infliximab
Subcutaneous infliximab in Crohn’s disease patients with previous immunogenic failure of intravenous infliximab
Duodenal Crohn’s disease successfully treated with adalimumab
Adalimumab for orbital myositis in a patient with Crohn’s disease who discontinued infliximab: a case report and review of the literature
Comparative real-world outcomes between ustekinumab, infliximab, and adalimumab in bio-naïve and bio-experienced Crohn’s disease patients: a retrospective multicenter study
Leukocytoclastic Vasculitis Associated with Adalimumab Therapy for Crohn’s Disease
Hodgkin's Lymphoma in Crohn's Disease Treated with Infliximab
Infliximab und Adalimumab in der Therapie der Colitis ulcerosa : eine retrospektive Analyse
Efficacy and safety of infliximab and adalimumab in inflammatory bowel disease patients
Listeria Monocytogenes Brain Abscess in Crohn’s Disease Treated with Adalimumab
Comparison between infliximab and adalimumab in the treatment of perianal fistulas in Crohn's disease
Adalimumab Dose-Escalation Therapy Is Effective in Refractory Crohn’s Disease Patients with Loss of Response to Adalimumab, Especially in Cases without Previous Infliximab Treatment
A Retrospective Claims Database Study on Drug Utilization in Japanese Patients with Crohn’s Disease Treated with Adalimumab or Infliximab
Subcutaneous infliximab in Crohn’s disease patients with previous immunogenic failure of intravenous infliximab
Duodenal Crohn’s disease successfully treated with adalimumab
Adalimumab for orbital myositis in a patient with Crohn’s disease who discontinued infliximab: a case report and review of the literature
Comparative real-world outcomes between ustekinumab, infliximab, and adalimumab in bio-naïve and bio-experienced Crohn’s disease patients: a retrospective multicenter study
Leukocytoclastic Vasculitis Associated with Adalimumab Therapy for Crohn’s Disease
Hodgkin's Lymphoma in Crohn's Disease Treated with Infliximab
Infliximab und Adalimumab in der Therapie der Colitis ulcerosa : eine retrospektive Analyse
Efficacy and safety of infliximab and adalimumab in inflammatory bowel disease patients